Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Identification of flocculant wine yeast strains with improved filtration-related phenotypes through application of high-throughput sedimentation rate assays.

Varela C, Bartel C, Nandorfy DE, Borneman A, Schmidt S, Curtin C.

Sci Rep. 2020 Feb 17;10(1):2738. doi: 10.1038/s41598-020-59579-y.

2.

Commercial Saccharomyces cerevisiae Yeast Strains Significantly Impact Shiraz Tannin and Polysaccharide Composition with Implications for Wine Colour and Astringency.

Bindon KA, Kassara S, Solomon M, Bartel C, Smith PA, Barker A, Curtin C.

Biomolecules. 2019 Sep 9;9(9). pii: E466. doi: 10.3390/biom9090466.

3.

Inactivating Mutations in Irc7p Are Common in Wine Yeasts, Attenuating Carbon-Sulfur β-Lyase Activity and Volatile Sulfur Compound Production.

Cordente AG, Borneman AR, Bartel C, Capone D, Solomon M, Roach M, Curtin CD.

Appl Environ Microbiol. 2019 Mar 6;85(6). pii: e02684-18. doi: 10.1128/AEM.02684-18. Print 2019 Mar 15.

4.

Complexes of N-hydroxyethyl-N-benzimidazolylmethylethylenediaminediacetic acid with group 12 metals and vanadium-Synthesis, structure and bioactivity of the vanadium complex.

Habala L, Bartel C, Giester G, Jakupec MA, Keppler BK, Rompel A.

J Inorg Biochem. 2015 Jun;147:147-52. doi: 10.1016/j.jinorgbio.2015.04.004. Epub 2015 Apr 11.

PMID:
25920686
5.

Assessing collective affect recognition via the Emotional Aperture Measure.

Sanchez-Burks J, Bartel CA, Rees L, Huy Q.

Cogn Emot. 2016;30(1):117-33. doi: 10.1080/02699931.2015.1015968. Epub 2015 Mar 26.

PMID:
25809581
6.

Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.

Tsiantoulas D, Perkmann T, Afonyushkin T, Mangold A, Prohaska TA, Papac-Milicevic N, Millischer V, Bartel C, Hörkkö S, Boulanger CM, Tsimikas S, Fischer MB, Witztum JL, Lang IM, Binder CJ.

J Lipid Res. 2015 Feb;56(2):440-8. doi: 10.1194/jlr.P054569. Epub 2014 Dec 18.

7.

Structure-activity relationships of targeted RuII(η6-p-cymene) anticancer complexes with flavonol-derived ligands.

Kurzwernhart A, Kandioller W, Bächler S, Bartel C, Martic S, Buczkowska M, Mühlgassner G, Jakupec MA, Kraatz HB, Bednarski PJ, Arion VB, Marko D, Keppler BK, Hartinger CG.

J Med Chem. 2012 Dec 13;55(23):10512-22. doi: 10.1021/jm301376a. Epub 2012 Nov 19.

PMID:
23134291
8.

Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells.

Mühlgassner G, Bartel C, Schmid WF, Jakupec MA, Arion VB, Keppler BK.

J Inorg Biochem. 2012 Nov;116:180-7. doi: 10.1016/j.jinorgbio.2012.06.003. Epub 2012 Jun 13.

9.

X-ray absorption spectroscopy of an investigational anticancer gallium(III) drug: interaction with serum proteins, elemental distribution pattern, and coordination of the compound in tissue.

Hummer AA, Bartel C, Arion VB, Jakupec MA, Meyer-Klaucke W, Geraki T, Quinn PD, Mijovilovich A, Keppler BK, Rompel A.

J Med Chem. 2012 Jun 14;55(11):5601-13. doi: 10.1021/jm3005459. Epub 2012 Jun 5.

PMID:
22621452
10.

Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder.

Kurzwernhart A, Kandioller W, Bartel C, Bächler S, Trondl R, Mühlgassner G, Jakupec MA, Arion VB, Marko D, Keppler BK, Hartinger CG.

Chem Commun (Camb). 2012 May 18;48(40):4839-41. doi: 10.1039/c2cc31040f. Epub 2012 Apr 12.

PMID:
22498692
11.

Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds.

Bartel C, Bytzek AK, Scaffidi-Domianello YY, Grabmann G, Jakupec MA, Hartinger CG, Galanski M, Keppler BK.

J Biol Inorg Chem. 2012 Mar;17(3):465-74. doi: 10.1007/s00775-011-0869-5. Epub 2012 Jan 7.

PMID:
22227950
12.

Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019.

Bartel C, Egger AE, Jakupec MA, Heffeter P, Galanski M, Berger W, Keppler BK.

J Biol Inorg Chem. 2011 Dec;16(8):1205-15. doi: 10.1007/s00775-011-0809-4. Epub 2011 Jun 26.

PMID:
21706338
13.

Physicochemical Studies and Anticancer Potency of Ruthenium η-p-Cymene Complexes Containing Antibacterial Quinolones.

Kljun J, Bytzek AK, Kandioller W, Bartel C, Jakupec MA, Hartinger CG, Keppler BK, Turel I.

Organometallics. 2011 May 9;30(9):2506-2512. Epub 2011 Apr 6.

14.

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339.

Heffeter P, Böck K, Atil B, Reza Hoda MA, Körner W, Bartel C, Jungwirth U, Keppler BK, Micksche M, Berger W, Koellensperger G.

J Biol Inorg Chem. 2010 Jun;15(5):737-48. doi: 10.1007/s00775-010-0642-1. Epub 2010 Mar 11.

15.

Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.

Kandioller W, Hartinger CG, Nazarov AA, Bartel C, Skocic M, Jakupec MA, Arion VB, Keppler BK.

Chemistry. 2009 Nov 16;15(45):12283-91. doi: 10.1002/chem.200901939.

PMID:
19821465
16.

Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.

Grguric-Sipka S, Stepanenko IN, Lazic JM, Bartel C, Jakupec MA, Arion VB, Keppler BK.

Dalton Trans. 2009 May 7;(17):3334-9. doi: 10.1039/b822725j. Epub 2009 Mar 12.

PMID:
19421637
17.

Performance in intercultural interactions at work: cross-cultural differences in response to behavioral mirroring.

Sanchez-Burks J, Bartel CA, Blount S.

J Appl Psychol. 2009 Jan;94(1):216-23. doi: 10.1037/a0012829.

PMID:
19186906

Supplemental Content

Loading ...
Support Center